Head-To-Head Survey: Intuitive Surgical (ISRG) & LeMaitre Vascular (LMAT)
Intuitive Surgical (NASDAQ: ISRG) and LeMaitre Vascular (NASDAQ:LMAT) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, analyst recommendations, profitability and institutional ownership.
Insider & Institutional Ownership
32.8% of Intuitive Surgical shares are held by institutional investors. Comparatively, 69.2% of LeMaitre Vascular shares are held by institutional investors. 2.2% of Intuitive Surgical shares are held by insiders. Comparatively, 23.7% of LeMaitre Vascular shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
This table compares Intuitive Surgical and LeMaitre Vascular’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Volatility and Risk
Intuitive Surgical has a beta of 0.47, indicating that its share price is 53% less volatile than the S&P 500. Comparatively, LeMaitre Vascular has a beta of 0.54, indicating that its share price is 46% less volatile than the S&P 500.
Valuation & Earnings
This table compares Intuitive Surgical and LeMaitre Vascular’s revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Intuitive Surgical||$2.70 billion||17.40||$735.90 million||$7.74||54.27|
|LeMaitre Vascular||$89.15 million||7.07||$10.59 million||$0.77||42.52|
Intuitive Surgical has higher revenue and earnings than LeMaitre Vascular. LeMaitre Vascular is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
This is a summary of current ratings and price targets for Intuitive Surgical and LeMaitre Vascular, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Intuitive Surgical currently has a consensus target price of $348.84, indicating a potential downside of 16.96%. LeMaitre Vascular has a consensus target price of $31.50, indicating a potential downside of 3.79%. Given LeMaitre Vascular’s higher probable upside, analysts plainly believe LeMaitre Vascular is more favorable than Intuitive Surgical.
LeMaitre Vascular pays an annual dividend of $0.22 per share and has a dividend yield of 0.7%. Intuitive Surgical does not pay a dividend. LeMaitre Vascular pays out 28.6% of its earnings in the form of a dividend.
Intuitive Surgical beats LeMaitre Vascular on 11 of the 16 factors compared between the two stocks.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc. (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation capability and three-dimensional (3-D), high-definition (HD) vision. Intuitive has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System, the da Vinci Si Surgical System, the da Vinci S Surgical System and the standard da Vinci Surgical System. The Company’s instruments and accessories include EndoWrist Instruments and da Vinci Single-Site.
LeMaitre Vascular Company Profile
LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company’s product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.